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IF1It is now clear that mitochondrial defects are associated with a large variety of clinical phenotypes. This is the
result of the mitochondria's central role in energy production, reactive oxygen species homeostasis, and cell
death. These processes are interdependent and may occur under various stressing conditions, among which
low oxygen levels (hypoxia) are certainly prominent. Cells exposed to hypoxia respond acutely with
endogenous metabolites and proteins promptly regulating metabolic pathways, but if low oxygen levels
are prolonged, cells activate adapting mechanisms, the master switch being the hypoxia-inducible factor 1
(HIF-1). Activation of this factor is strictly bound to the mitochondrial function, which in turn is related with
the oxygen level. Therefore in hypoxia, mitochondria act as [O2] sensors, convey signals to HIF-1directly or
indirectly, and contribute to the cell redox potential, ion homeostasis, and energy production. Although over
the last two decades cellular responses to low oxygen tension have been studied extensively, mechanisms
underlying these functions are still indeﬁnite. Here we review current knowledge of the mitochondrial role
in hypoxia, focusing mainly on their role in cellular energy and reactive oxygen species homeostasis in
relation with HIF-1 stabilization. In addition, we address the involvement of HIF-1 and the inhibitor protein
of F1F0 ATPase in the hypoxia-induced mitochondrial autophagy., hypoxia-inducible factor; IF1,
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Over the last two decades a defective mitochondrial function
associated with hypoxia has been invoked in many diverse complex
disorders, such as type 2 diabetes [1,2], Alzheimer's disease [3,4],
cardiac ischemia/reperfusion injury [5,6], tissue inﬂammation [7], and
cancer [8–12].
The [O2] in air-saturated aqueous buffer at 37 °C is approx. 200 μM
[13]; however, mitochondria in vivo are exposed to a considerably
lower [O2] that varies with tissue and physiological state. Under
physiological conditions, most human resting cells experience some
5% oxygen tension, however the [O2] gradient occurring between the
extracellular environment and mitochondria, where oxygen is con-
sumed by cytochrome c oxidase, results in a signiﬁcantly lower [O2]
exposition of mitochondria. Below this oxygen level, most mam-
malian tissues are exposed to hypoxic conditions [14]. These may
arise in normal development, or as a consequence of pathophysio-logical conditions where there is a reduced oxygen supply due to a
respiratory insufﬁciency or to a defective vasculature. Such conditions
include inﬂammatory diseases, diabetes, ischemic disorders (cerebral
or cardiovascular), and solid tumors. Mitochondria consume the
greatest amount (some 85–90%) of oxygen in cells to allow oxidative
phosphorylation (OXPHOS), which is the primary metabolic pathway
for ATP production. Therefore hypoxia will hamper this metabolic
pathway, and if the oxygen level is very low, insufﬁcient ATP avail-
ability might result in cell death [15].
When cells are exposed to an atmosphere with reduced oxygen
concentration, cells readily “respond” by inducing adaptive reactions
for their survival through the AMP-activated protein kinase (AMPK)
pathway (see for a recent review [16]) which inter alia increases
glycolysis driven by enhanced catalytic efﬁciency of some enzymes,
including phosphofructokinase-1 and pyruvate kinase (of note, this
oxidative ﬂux is thermodynamically allowed due to both reduced
phosphorylation potential [ATP]/([ADP][Pi]) and the physiological
redox state of the cell). However, this is particularly efﬁcient only in
the short term, therefore cells respond to prolonged hypoxia also by
stimulation of hypoxia-inducible factors (HIFs: HIF-1 being themostly
studied), which are heterodimeric transcription factors composed of
α and β subunits, ﬁrst described by Semenza and Wang [17]. These
HIFs in the presence of hypoxic oxygen levels are activated through
a complex mechanism in which the oxygen tension is critical (see
below). Afterwards HIFs bind to hypoxia-responsive elements,
activating the transcription of more than two hundred genes that
allow cells to adapt to the hypoxic environment [18,19].
1172 G. Solaini et al. / Biochimica et Biophysica Acta 1797 (2010) 1171–1177Several excellent reviews appeared in the last few years de-
scribing the array of changes induced by oxygen deﬁciency in both
isolated cells and animal tissues. In in vivo models, a coordinated
regulation of tissue perfusion through vasoactive molecules such
as nitric oxide and the action of carotid bodies rapidly respond to
changes in oxygen demand [20–24]. Within isolated cells, hypoxia
induces signiﬁcant metabolic changes due to both variation of
metabolites level and activation/inhibition of enzymes and trans-
porters; themost important intracellular effects induced by different
pathways are expertly described elsewhere (for recent reviews,
see [25–27]). It is reasonable to suppose that the type of cells
and both the severity and duration of hypoxia may determine which
pathways are activated/depressed and their timing of onset
[3,6,10,12,23,28]. These pathwayswill eventually lead to preferential
translation of key proteins required for adaptation and survival
to hypoxic stress. Although in the past two decades, the discovery
of HIF-1 by Gregg Semenza et al. provided a molecular platform to
investigate the mechanism underlying responses to oxygen depri-
vation, the molecular and cellular biology of hypoxia has still to be
completely elucidated. This review summarizes recent experimental
data concerned with mitochondrial structure and function adapta-
tion to hypoxia and evaluates it in light of the main structural and
functional parameters deﬁning the mitochondrial bioenergetics.
Since mitochondria contain an inhibitor protein, IF1, whose action
on the F1F0 ATPase has been considered for decades of critical
importance in hypoxia/ischemia, particular notice will be dedicated
to analyze molecular aspects of IF1 regulation of the enzyme and
its possible role in the metabolic changes induced by low oxygen
levels in cells.2. Mechanism(s) of HIF-1 activation
HIF-1 consists of an oxygen-sensitive HIF-1α subunit that
heterodimerizes with the HIF-1β subunit to bind DNA. In high O2
tension, HIF-1α is oxidized (hydroxylated) by prolyl hydroxylases
(PHDs) using α-ketoglutarate derived from the tricarboxylic acid
(TCA) cycle. The hydroxylated HIF-1α subunit interacts with the von
Hippel–Lindau protein, a critical member of an E3 ubiquitin ligase
complex that polyubiquitylates HIF. This is then catabolized by
proteasomes, such that HIF-1α is continuously synthesized and
degraded under normoxic conditions [18]. Under hypoxia, HIF-1α
hydroxylation does not occur, thereby stabilizing HIF-1 (Fig. 1).
The active HIF-1 complex in turn binds to a core hypoxia response
element in a wide array of genes involved in a diversity of biological
processes, and directly transactivates glycolytic enzyme genes [29].
Notably, O2 concentration, multiple mitochondrial products, in-
cluding the TCA cycle intermediates and reactive oxygen species, can
coordinate PHD activity, HIF stabilization, hence the cellular
responses to O2 depletion [30,31]. Incidentally, impaired TCA cycle
ﬂux, particularly if it is caused by succinate dehydrogenase dys-
function, results in decreased or loss of energy production from
both the electron-transport chain and the Krebs cycle, and also in
overproduction of free radicals [32]. This leads to severe early-onset
neurodegeneration or, as it occurs in individuals carrying mutations
in the non-catalytic subunits of the same enzyme, to tumors such
as phaeochromocytoma and paraganglioma. However, impairment
of the TCA cycle may be relevant also for the metabolic changes
occurring inmitochondria exposed to hypoxia, since accumulation of
succinate has been reported to inhibit PHDs [33]. It has to be noticed
that some authors believe reactive oxygen species (ROS) to be
essential to activate HIF-1 [34], but others challenge this idea [35],
therefore the role of mitochondrial ROS in the regulation of HIF-1
under hypoxia is still controversial [36]. Moreover, the contribution
of functional mitochondria to HIF-1 regulation has also been
questioned by others [37–39].3. Effects of reduced oxygen level on energy metabolism in cells
Oxygen is a major determinant of cell metabolism and gene ex-
pression, and as cellular O2 levels decrease, either during isolated
hypoxia or ischemia-associated hypoxia, metabolism and gene ex-
pression proﬁles in the cells are signiﬁcantly altered. Low oxygen
reduces OXPHOS and Krebs cycle rates, and participates in the
generation of nitric oxide (NO), which also contributes to decrease
respiration rate [23,40]. However, oxygen is also central in the
generation of reactive oxygen species, which can participate in cell
signaling processes or can induce irreversible cellular damage and
death [41].
As speciﬁed above, cells adapt to oxygen reduction by inducing
active HIF, whose major effect on cells energy homeostasis is the
inactivation of anabolism, activation of anaerobic glycolysis, and
inhibition of the mitochondrial aerobic metabolism: the TCA cycle,
and OXPHOS. Since OXPHOS supplies the majority of ATP required for
cellular processes, low oxygen tensionwill severely reduce cell energy
availability. This occurs through several mechanisms: ﬁrst, reduced
oxygen tension decreases the respiration rate, due ﬁrst to nonsatur-
ating substrate for cytochrome c oxidase (COX), secondarily, to
allosteric modulation of COX [42]. As a consequence, the phosphor-
ylation potential decreases, with enhancement of the glycolysis rate
primarily due to allosteric increase of phosphofructokinase activity;
glycolysis however is poorly efﬁcient and produces lactate in pro-
portion of 0.5 mol/mol ATP, which eventually drops cellular pH if cells
are not well perfused, as it occurs under defective vasculature or
ischemic conditions [6]. Besides this “spontaneous” (thermodynam-
ically-driven) shift from aerobic to anaerobic metabolism which is
mediated by the kinetic changes of most enzymes, the HIF-1 factor
activates transcription of genes encoding glucose transporters and
glycolytic enzymes to further increase ﬂux of reducing equivalents
from glucose to lactate [43,44]. Second, HIF-1 coordinates two dif-
ferent actions on the mitochondrial phase of glucose oxidation: it
activates transcription of the PDK1 gene encoding a kinase that
phosphorylates and inactivates pyruvate dehydrogenase, thereby
shunting away pyruvate from the mitochondria by preventing its
oxidative decarboxylation to acetyl-CoA [45,46]. Moreover, HIF-1
induces a switch in the composition of cytochrome c oxidase from
COX4-1 to COX4-2 isoform, which enhances the speciﬁc activity of the
enzyme. As a result, both respiration rate and ATP level of hypoxic
cells carrying the COX4-2 isoform of cytochrome c oxidase were found
signiﬁcantly increased with respect to the same cells carrying the
COX4-1 isoform [47]. Incidentally, HIF-1 can also increase the
expression of carbonic anhydrase 9, which catalyses the reversible
hydration of CO2 to HCO3− and H+, therefore contributing to pH
regulation.
4. Effect of reduced oxygen level on mitochondria
4.1. Effects of hypoxia on mitochondrial structure and dynamics
Mitochondria form a highly dynamic tubular network, the
morphology of which is regulated by frequent ﬁssion and fusion
events. The fusion/ﬁssion machineries are modulated in response
to changes in the metabolic conditions of the cell, therefore one
should expect that hypoxia affect mitochondrial dynamics. Oxygen
availability to cells decreases glucose oxidation, whereas oxygen
shortage consumes glucose faster in an attempt to produce ATP via
the less efﬁcient anaerobic glycolysis to lactate (Pasteur effect). Under
these conditions, mitochondria are not fueled with substrates (acetyl-
CoA and O2), inducing major changes of structure, function, and
dynamics (for a recent review see [48]). Concerning structure and
dynamics, one of the ﬁrst correlates that emerge is that impairment
of mitochondrial fusion leads to mitochondrial depolarization, loss
of mtDNA that may be accompanied by altered respiration rate, and
Fig. 1.Major mitochondrial changes in hypoxia. Hypoxia could decrease electron-transport rate determining Δψm reduction, increased ROS generation, and enhanced NO synthase.
One (or more) of these factors likely contributes to HIF stabilization, that in turn induces metabolic adaptation of both hypoxic cells and mitophagy. The decreased Δψm could also
induce an active binding of IF1, which might change mitochondrial morphology and/or dynamics, and inhibit mitophagy. Solid lines indicate well established hypoxic changes in
cells, whilst dotted lines indicate changes not yet stated. Inset, relationships between extracellular O2 concentration and oxygen tension.
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Indeed, exposure of cortical neurons to moderate hypoxic conditions
for several hours, signiﬁcantly altered mitochondrial morphology,
decreased mitochondrial size and reduced mitochondrial mean
velocity. Since these effects were either prevented by exposing the
neurons to inhibitors of nitric oxide synthase or mimicked by NO
donors in normoxia, the involvement of an NO-mediated pathway
was suggested [52]. Mitochondrial motility was also found inhibited
and controlled locally by the [ADP]/[ATP] ratio [53]. Interestingly, the
author used an original approach in which mitochondria were
visualized using tetramethylrhodamineethylester and their move-
ments were followed by applying single-particle tracking.
Of notice in this chapter is that enzymes controlling mitochondrial
morphology regulators provide a platform through which cellular
signals are transduced within the cell in order to affect mitochondrial
function [54]. Accordingly, one might expect that besides other
mitochondrial factors [30,55] playing roles in HIF stabilization, also
mitochondrial morphology might reasonably be associated with HIF
stabilization. In order to better deﬁne the mechanisms involved in the
morphology changes of mitochondria and in their dynamics when
cells experience hypoxic conditions, these pioneering studies should
be corroborated by and extended to observations on other types of
cells focusing also on single proteins involved in both mitochondrial
fusion/ﬁssion and motion.
4.2. Effects of hypoxia on the respiratory chain complexes
O2 is the terminal acceptor of electrons from cytochrome c oxidase
(Complex IV), which has a very high afﬁnity for it, being the oxygen
concentration for half-maximal respiratory rate at pH7.4 approximately
0.7 µM [56]. Measurements ofmitochondrial oxidative phosphorylation
indicated that it is not dependent on oxygen concentration up to at
least 20 µM at pH 7.0 and the oxygen dependence becomes markedly
greater as the pH is more alkaline [56]. Similarly, Moncada et al.
[57] found that the rate of O2 consumption remained constant until
[O2] fell below 15 µM. Accordingly, most reports in the literature
consider hypoxic conditions occurring in cells at 5–0.5% O2, a rangecorresponding to 46–4.6 µM O2 in the cells culture medium (see Fig. 1
inset). Since between the extracellular environment and mitochondria
an oxygen pressure gradient is established [58], the O2 concentration
experienced by Complex IV falls in the range affecting its kinetics, as
reported above.
Under these conditions, a number of changes on the OXPHOS
machinery components, mostly mediated by HIF-1 have been found.
Thus, Semenza et al. [59] and others thereafter [46] reported that
activation of HIF-1α induces pyruvate dehydrogenase kinase, which
inhibits pyruvate dehydrogenase, suggesting that respiration is
decreased by substrate limitation. Besides, other HIF-1 dependent
mechanisms capable to affect respiration rate have been reported.
First, the subunit composition of COX is altered in hypoxic cells by
increased degradation of the COX4-1 subunit, which optimizes COX
activity under aerobic conditions, and increased expression of the
COX4-2 subunit, which optimizes COX activity under hypoxic con-
ditions [29]. On the other hand, direct assay of respiration rate in cells
exposed to hypoxia resulted in a signiﬁcant reduction of respiration
[60]. According with the evidence of Zhang et al., the respiration rate
decrease has to be ascribed to mitochondrial autophagy, due to HIF-1-
mediated expression of BNIP3. This interpretation is in line with
preliminary results obtained in our laboratory where the assay of the
citrate synthase activity of cells exposed to different oxygen tensions
was performed. Fig. 2 shows the citrate synthase activity, which is
taken as an index of the mitochondrial mass [11], with respect to
oxygen tension: [O2] and mitochondrial mass are directly linked.
However, the observations of Semenza et al. must be seen in
relation with data reported by Moncada et al. [57] and conﬁrmed by
others [61] in which it is clearly shown that when cells (various cell
lines) experience hypoxic conditions, nitric oxide synthases (NOSs)
are activated, therefore NO is released. As already mentioned above,
NO is a strong competitor of O2 for cytochrome c oxidase, whose
apparent Km results increased, hence reduction of mitochondrial
cytochromes and all the other redox centres of the respiratory chain
occurs. In addition, very recent data indicate a potential de-activation
of Complex I when oxygen is lacking, as it occurs in prolonged hypoxia
[62]. According to Hagen et al. [63] the NO-dependent inhibition of
Fig. 2. Citrate synthase activity. Human primary ﬁbroblasts, obtained from skin biopsies
of 5 healthy donors, were seeded at a density of 8,000 cells/cm2 in high glucose
Dulbecco's Modiﬁed Eagle Medium, DMEM (25 mM glucose, 110 mg/l pyruvate, and
4 mM glutamine) supplemented with 15% Foetal Bovine Serum (FBS). 18 h later, cell
culture dishes were washed once with Hank's Balanced Salt Solution (HBSS) and the
medium was replaced with DMEM containing 5 mM glucose, 110 mg/l pyruvate, and
4 mM glutamine supplemented with 15% FBS. Cell culture dishes were then placed into
an INVIVO2 humidiﬁed hypoxia workstation (Ruskinn Technologies, Bridgend, UK) for
72 h changing the medium at 48 h, and oxygen partial pressure (tension) conditions
were: 20%, 4%, 2%, 1% and 0.5%. Cells were subsequently collected within the work-
station with trypsin-EDTA (0.25%), washed with PBS and resuspended in a buffer
containing 10 mM Tris/HCl, 0.1 M KCl, 5 mM KH2PO4, 1 mM EGTA, 3 mM EDTA, and
2 mM MgCl2 pH 7.4 (all the solutions were preconditioned to the appropriate oxygen
tension condition). The citrate synthase activity was assayed essentially by incubating
40 µg of cells with 0.02% Triton X-100, and monitoring the reaction by measuring
spectrophotometrically the rate of free coenzyme A released, as described in [90].
Enzymatic activity was expressed as nmol/min/mg of protein. Three independent
experiments were carried out and assays were performed in either duplicate or
triplicate.
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the cell to be used by other enzymes, including PHDs which inactivate
HIF. Therefore, unless NO inhibition of cytochrome c oxidase occurs
only when [O2] is very low, inhibition of mitochondrial oxygen con-
sumption creates the paradox of a situation in which the cell may
fail to register hypoxia. It has been tempted to solve this paradox, but
to date only hypotheses have been proposed [23,26]. Interestingly,
recent observations on yeast cells exposed to hypoxia revealed
abnormal protein carbonylation and protein tyrosine nitration that
were ascribed to increased mitochondrially generated superoxide
radicals and NO, two species typically produced at low oxygen levels,
that combine to form ONOO− [64]. Based on these studies a possible
explanation has been proposed for the above paradox.
Finally, it has to be noticed that the mitochondrial respiratory
deﬁciency observed in cardiomyocytes of dogs in which experimental
heart failure had been induced lies in the supermolecular assembly
rather than in the individual components of the electron-transport
chain [65]. This observation is particularly intriguing since loss of
respirasomes is thought to facilitate ROS generation in mitochondria
[66], therefore supercomplexes disassembly might explain the para-
dox of reduced [O2] and the enhanced ROS found in hypoxic cells.
Speciﬁcally, hypoxia could reduce mitochondrial fusion by impairing
mitochondrial membrane potential, which in turn could induce
supercomplexes disassembly, increasing ROS production [11].
4.3. Complex III and ROS production
It has been estimated that, under normoxic physiological conditions,
1–2% of electron ﬂow through themitochondrial respiratory chain gives
rise to ROS [67,68]. It is now recognized that the major sites of ROS
production are within Complexes I and III, being prevalent the
contribution of Complex I [69] (Fig. 3). It might be expected that
hypoxia would decrease ROS production, due to the low level of O2 and
to the diminished mitochondrial respiration [6,46], but ROS level is
paradoxically increased. Indeed, about a decade ago, Chandel et al. [70]
provided good evidence that mitochondrial reactive oxygen speciestrigger hypoxia-induced transcription, and a few years later the same
group [71] showed that ROS generated at Complex III of the
mitochondrial respiratory chain stabilize HIF-1α during hypoxia
(Figs. 1 and 3). Although others have proposed mechanisms indicating
a key role of mitochondria in HIF-1α regulation during hypoxia (for
reviews see [64,72]), the contribution of mitochondria to HIF-1
regulation has been questioned by others [35–37]. Results of Gong
and Agani [35] for instance show that inhibition of electron-transport
Complexes I, III, and IV, as well as inhibition of mitochondrial F0F1
ATPase, prevents HIF-1α expression and that mitochondrial reactive
oxygen species are not involved in HIF-1α regulation during hypoxia.
Concurrently, Tuttle et al. [73], bymeans of a non invasive, spectroscopic
approach, could ﬁnd no evidence to suggest that ROS, produced by
mitochondria, are needed to stabilize HIF-1α under moderate hypoxia.
The sameauthors found the levels of HIF-1α comparable in both normal
and ρ0 cells (i.e. cells lacking mitochondrial DNA). On the contrary,
experiments carried out on genetic models consisting of either cells
lacking cytochrome c or ρ0 cells both could evidence the essential role of
mitochondrial respiration to stabilize HIF-1α [74]. Thus, cytochrome c
null cells, being incapable to respire, exposed to moderate hypoxia
(1.5% O2) prevented oxidation of ubiquinol and generation of the
ubisemiquinone radical, thus eliminating superoxide formation at
Complex III [71]. Concurrently, ρ0 cells lacking electron transport,
exposed 4 h to moderate hypoxia failed to stabilize HIF-1α, suggesting
the essential role of the respiratory chain for the cellular sensing of low
O2 levels. In addition, recent evidence obtained on genetic manipulated
cells (i.e. cytochrome b deﬁcient cybrids) showed increased ROS levels
and stabilized HIF-1α protein during hypoxia [75]. Moreover, RNA
interference of the Complex III subunit Rieske iron sulfur protein in the
cytochrome b deﬁcient cells, abolished ROS generation at the Qo site of
Complex III, preventing HIF-1α stabilization. These observations,
substantiated by experiments with MitoQ, an efﬁcient mitochondria-
targeted antioxidant, strongly support the involvement of mitochon-
drial ROS in regulating HIF-1α. Nonetheless, collectively, the available
data do not allow to deﬁnitely state the precise role of mitochondrial
ROS in regulating HIF-1α, but the pathway stabilizing HIF-1α appears
undoubtedly mitochondria-dependent [30].
4.4. Hypoxia and ATP synthase
The F1F0 ATPase (ATP synthase) is the enzyme responsible of
catalysing ADP phosphorylation as the last step of OXPHOS. It is a
rotary motor using the proton motive force across the mitochondrial
inner membrane to drive the synthesis of ATP [76]. It is a reversible
enzyme with ATP synthesis or hydrolysis taking place in the F1 sector
at the matrix side of the membrane, chemical catalysis being coupled
to H+ transport through the transmembrane F0 sector.
Under normoxia the enzyme synthesizes ATP, but when mito-
chondria experience hypoxic conditions the mitochondrial mem-
brane potential (Δψm) decreases below its endogenous steady-state
level (some 140 mV, negative inside the matrix [77]) and the F1F0
ATPase may work in the reversal mode: it hydrolyses ATP (produced
by anaerobic glycolysis) and uses the energy released to pump
protons from the mitochondrial matrix to the intermembrane space,
concurring with the adenine nucleotide translocator (i.e. in hypoxia
it exchanges cytosolic ATP4− for matrix ADP3−) to maintain the
physiological Δψm (Fig. 3). Since under conditions of limited oxygen
availability the decline in cytoplasmic high energy phosphates is
mainly due to hydrolysis by the ATP synthase working in reverse
[6,78], the enzyme must be strictly regulated in order to avoid ATP
dissipation. This is achieved by a natural protein, the H+/Δψm-
dependent IF1, that binds to the catalytic F1 sector at low pH and low
Δψm (such as it occurs in hypoxia/ischemia) [79]. IF1 binding to the
ATP synthase results in a rapid and reversible inhibition of the
enzyme [80], which could reach about 50% of maximal activity (for
recent reviews see [6,81]).
Fig. 3. Overview of mitochondrial electron and proton ﬂux in hypoxia. Electrons released from reduced cofactors (NADH and FADH2) under normoxia ﬂow through the redox centres
of the respiratory chain (r.c.) to molecular oxygen (blue dotted line), to which a proton ﬂux from the mitochondrial matrix to the intermembrane space is coupled (blue arrows).
Protons then ﬂow back to thematrix through the F0 sector of the ATP synthase complex, driving ATP synthesis. ATP is carried to the cell cytosol by the adenine nucleotide translocator
(blue arrows). Under moderate to severe hypoxia, electrons escape the r.c. redox centres and reduce molecular oxygen to the superoxide anion radical before reaching the
cytochrome c (red arrow). Under these conditions, to maintain an appropriate Δψm, ATP produced by cytosolic glycolysis enters the mitochondria where it is hydrolyzed by the F1F0
ATPase with extrusion of protons from the mitochondrial matrix (red arrows).
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with ROS production and mitochondrial autophagy (mitophagy). This
is a mechanism involving the catabolic degradation of macromole-
cules and organelles via the lysosomal pathway that contributes to
housekeeping and regenerate metabolites. Autophagic degradation is
involved in the regulation of the ageing process and in several human
diseases, such as myocardial ischemia/reperfusion [82], Alzheimer's
Disease, Huntington diseases, and inﬂammatory diseases (for recent
reviews see [83,84], and, asmentioned above, it promotes cell survival
by reducing ROS and mtDNA damage under hypoxic conditions.
Campanella et al. [81] reported that, in HeLa cells under normoxic
conditions, basal autophagic activity varies in relation to the expression
levels of IF1. Accordingly, cells overexpressing IF1 result in ROS
production similar to controls, conversely cells in which IF1 expression
is suppressed show an enhanced ROS production. In parallel, the latter
cells show activation of the mitophagy pathway (Fig. 1), therefore
suggesting that variations in IF1 expression level may play a signiﬁcant
role in deﬁning two particularly important parameters in the context of
the current review: rates of ROS generation and mitophagy. Thus, the
hypoxia-induced enhanced expression level of IF1 [81] should be
associated with a decrease of both ROS production and autophagy,
which is in apparent conﬂict with the hypoxia-induced ROS increase
and with the HIF-1-dependent mitochondrial autophagy shown by
Zhanget al. [60] as anadaptivemetabolic response tohypoxia.However,
in the experiments of Zhang et al. the cells were exposed to hypoxia for
48 h, whereas the F1F0-ATPase inhibitor exerts a prompt action on the
enzyme and to our knowledge, it has never been reported whether its
action persists during prolonged hypoxic expositions. Pertinent with
this problem is the very recent observation that IEX-1 (immediate early
response gene X-1), a stress-inducible gene that suppresses production
of ROS and protects cells from apoptosis [85], targets the mitochondrialF1F0-ATPase inhibitor for degradation, reducing ROS by decreasingΔψm.
It has to be noticed that the experiments described were carried out
under normal oxygen availability, but it does not seem reasonable to
rule out IEX-1 from playing a role under stress conditions as those
induced by hypoxia in cells, therefore this issue might deserve an
investigation also at low oxygen levels.
In conclusion, data are still emerging regarding the regulation of
mitochondrial function by the F1F0 ATPase within hypoxic responses
in different cellular and physiological contexts. Given the broad path-
ophysiological role of hypoxic cellular modulation, an understanding
of the subtle tuning among different effectors of the ATP synthase is
desirable to eventually target future therapeutics most effectively. Our
laboratory is actually involved in carrying out investigations to clarify
this context.
5. Conclusions and perspectives
The mitochondria are important cellular platforms that both prop-
agate and initiate intracellular signals that lead to overall cellular and
metabolic responses. During the last decades, a signiﬁcant amount
of relevant data has been obtained on the identiﬁcation of mechan-
isms of cellular adaptation to hypoxia. In hypoxic cells there is an
enhanced transcription and synthesis of several glycolytic pathway
enzymes/transporters and reduction of synthesis of proteins involved
in mitochondrial catabolism. Although well deﬁned kinetic para-
meters of reactions in hypoxia are lacking, it is usually assumed that
these transcriptional changes lead to metabolic ﬂux modiﬁcation. The
required biochemical experimentation has been scarcely addressed
until now and only in few of themolecular and cellular biology studies
the transporter and enzyme kinetic parameters and ﬂux rate have
been determined, leaving some uncertainties.
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electrochemical proton gradient across the mitochondrial inner
membrane that is established by the proton pumping activity of the
respiratory chain, and that is strictly linked to the F1F0-ATPase func-
tion. Evaluation of the mitochondrial membrane potential in hypoxia
has only been studied using semiquantitative methods based on
measurements of the ﬂuorescence intensity of probes taken up by
cells experiencing normal or hypoxic conditions. However, this
approach is intrinsically incorrect due to the different capability that
molecular oxygen has to quench ﬂuorescence [86,87] and to the
uncertain concentration the probe attains within mitochondria,
whose mass may be reduced by a half in hypoxia [60]. In addition,
the uncertainty about measurement of mitochondrial superoxide
radical and H2O2 formation in vivo [88] hampers studies on the role of
mitochondrial ROS in hypoxic oxidative damage, redox signaling, and
HIF-1 stabilization.
The duration and severity of hypoxic stress differentially activate the
responses discussed throughout and lead to substantial phenotypic
variations amongst tissues and cell models, which are not consistently
and deﬁnitely known. Certainly, understanding whether a hierarchy
among hypoxia response mechanisms exists and which are the precise
timing and conditions of each mechanism to activate, will improve our
knowledge of the biochemical mechanisms underlying hypoxia in cells,
which eventually may contribute to deﬁne therapeutic targets in
hypoxia-associated diseases. To this aim it might be worth investigating
the hypoxia-induced structural organization of both the respiratory
chain enzymes in supramolecular complexes and the assembly of the
ATP synthase to form oligomers affecting ROS production [65] and inner
mitochondrial membrane structure [89], respectively. An investigation
indue course inour laboratory suggests a signiﬁcant inﬂuenceofhypoxic
conditions to induce reduction of mitochondrial mass and respiratory
chain complexes, andmorphology changes (manuscript in preparation).
Future work will continue to explore hypoxia-induced effects
and help to position mitochondrial function, dynamics and signaling
within multiple cellular pathways, including those involved in many
diverse complex disorders, such as tumors, ischemic injury, complica-
tions of diabetes, and hypoxia-associated neurodegeneration.References
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